Summary

Y-mAbs Therapeutics Inc

Founded in 2017

Strengths

  • Y-mAbs Therapeutics Inc has a strong market share in their industry
  • The number of employees is growing faster than the industry average
  • Revenue growth is more steady than the industry average
  • Since Y-mAbs Therapeutics Inc was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Revenue generated per employee is less than the industry average
  • Revenue growth is less than the industry average

Annual Revenue

Y-mAbs Therapeutics Inc's annual revenue

$40000000

Based on Kona Equity data

  • Revenue per employee

    $270270

  • Variance of revenue growth

    0.03

  • Annual revenue growth since founding

    $1070571

  • Revenue growth rate from first known quarter to current

    -45.7%

Employee Count

148 employees

  • Employee growth rate from first known quarter to current

    -5.8%

Executives

Mahiuddin Ahmed

Senior Vice President, Cso

m**@ymabs.com

G Score - 5

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G5 Variance of revenue growth is less than the industry average
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    1.87 M

  • Page views per visitor

    2.0

  • Daily time

    2:06

Location

230 Park Avenue, Suite 3350 
New York City, NY  10169

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Otonomy

otonomy.com
  • Founded in 2008
  • Location: San Diego, CA
  • Annual Revenue: $35.0K
  • Employees: 51
  • In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor v...

TG Therapeutics

tgtherapeutics.com
  • Founded in 2012
  • Location: New York City, NY
  • Annual Revenue: $7.9M
  • Employees: 286
  • TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies tar...

Harbour BioMed

harbourbiomed.com
  • Founded in 2016
  • Location: Cambridge, MA
  • Annual Revenue: $4.3M
  • Employees: 396
  • Harbour BioMed (HBM Holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological diseases.

Allakos, Inc.

allakos.com
  • Founded in 2012
  • Location: San Carlos, California
  • Annual Revenue: $64.8M
  • Employees: 192
  • Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases

NGM Bio

ngmbio.com
  • Founded in 2008
  • Location: South San Francisco, CA
  • Annual Revenue: $77.3M
  • Employees: 225
  • NGM Bio is a biopharmaceutical company that is focused on harnessing powerful human biology to develop transformative therapeutics for patients. They have a broad and diverse pipeline of novel medicines that target a range of therapeutic areas and dise...

Agenus Inc

agenusbio.com
  • Founded in 1994
  • Location: Basel, MA
  • Annual Revenue: $309.9M
  • Employees: 441
  • Agenus is an immuno-oncology company that develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. Their mission is to harness the power of the immune system to bring curative therapies to cancer patients. They focus...

Key Information

  • SIC: 28; 283
  • NAICS: 32541; 42421
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Y-mAbs Therapeutics Inc.

See similar companies

Frequently Asked Questions

Where is Y-mAbs Therapeutics Inc located?

Y-mAbs Therapeutics Inc's headquarters are located at 230 Park Avenue, Suite 3350  New York City, NY  10169.


What is Y-mAbs Therapeutics Inc's official website?

Y-mAbs Therapeutics Inc's official website is ymabs.com


What is Y-mAbs Therapeutics Inc's revenue?

Y-mAbs Therapeutics Inc's annual revenue is $40.0 M.


What is Y-mAbs Therapeutics Inc's SIC code?

Y-mAbs Therapeutics Inc's SIC: 28; 283


What is Y-mAbs Therapeutics Inc's NAICS code?

Y-mAbs Therapeutics Inc's NAICS: 32541; 42421.


How many employees does Y-mAbs Therapeutics Inc's have?

Y-mAbs Therapeutics Inc has 148 employees


What industry does Y-mAbs Therapeutics Inc belong to?

Y-mAbs Therapeutics Inc is in the industry of Biotechnology.

Next step

Visitors review